Tag Archives: TB drug

TB Alliance Sublicenses Promising Anti-Tuberculosis Drug from the Medicines Patent Pool

Herman Opondo On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to the development of sutezolid in combination with other TB drugs and follows the MPP’s license for

Top